Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Journal of Alzheimer'S Disease : JAD|August 6, 2019
Causative Mutations and Genetic Risk Factors in Sporadic Early Onset Alzheimer's Disease Before 51 YearsMorgane Lacour, Olivier Quenez, Anne Rovelet-Lecrux, et al.
Alzheimer'S Research & Therapy|August 31, 2017
Cognitive and imaging markers in non-demented subjects attending a memory clinic: study design and baseline findings of the MEMENTO cohortCarole Dufouil, Bruno Dubois, Bruno Vellas, et al.
European Journal of Human Genetics : EJHG|August 6, 2015
Screening of dementia genes by whole-exome sequencing in early-onset Alzheimer disease: input and lessonsGaël Nicolas, David Wallon, Camille Charbonnier, et al.
Alzheimer'S Research & Therapy|May 11, 2023
Phenotype and imaging features associated with APP duplicationsLou Grangeon, Camille Charbonnier, Aline Zarea, et al.
Molecular Psychiatry|July 11, 2020
Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brainIvan Alić, Pollyanna A Goh, Aoife Murray, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 9, 2019
Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studiesYi Su, Shaney Flores, Guoqiao Wang, et al.
Molecular Psychiatry|May 29, 2026
Assessing the de novo paradigm in sporadic early-onset Alzheimer disease triosAline Zarea, Kevin Cassinari, François Lecoquierre, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 23, 2025
The relationship of soluble tau species with Alzheimer's disease amyloid plaque removal and tau pathologyEric M McDade, Nicolas R Barthélemy, Guoqiao Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 5, 2023
Longitudinal head-to-head comparison of <sup>11</sup>C-PiB and <sup>18</sup>F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's diseaseCharles D Chen, Austin McCullough, Brian Gordon, et al.
Annals of Neurology|September 24, 2022
Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer DiseaseNelly Joseph-Mathurin, Jorge J Llibre-Guerra, Yan Li, et al.
Pageof 12